Amnio Technology is an industry leader in the development and manufacture of amnion-derived technologies.
Amnio Technology is committed to developing innovative products that provide regenerative therapies for unmet and underserved wound care and orthopedic needs.
Explore our amniotic allografts that offer convenience without compromise.
Learn how we are different from every other manufacturer on the market.
Amnio Technology manufactures high-quality, chorion-free products to reduce the potential for graft-versus-host autoimmune response.
Our products meet or exceed the Quality and donor testing expectations set by the FDA in 21 CFR 1271.
HCPCS codes specifically for the PalinGen® brand that has its own Q code.
Our products are derived from amniotic tissues recovered under strict guidelines and policies without harming the mother or child.
PalinGen® products are manufactured using our proprietary Advantec© process, that excludes the chorion layer.
Every product is processed and packaged according to cGTP (current good tissue practices) regulations.
Quick delivery to clinicians nationwide to improve quality of life for patients in need.
An industry leader in the development and manufacture of amnion-derived technologies
Copyright © 2024 Amnio Technology, LLC
